← Open Payments lookup

BRIAN BRADY: Open Payments

NPI 1225613094 · BALTIMORE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,612 in 93 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $1,607 · 2025 $1,612

Food & beverage: $1,612
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.17$347
E.R. Squibb & Sons, L.L.C.14$263
Teva Pharmaceuticals USA, Inc.10$234
ABBVIE INC.25$183
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)8$171
Alkermes, Inc.8$160
Janssen Pharmaceuticals, Inc4$119
Otsuka America Pharmaceutical, Inc.5$93
Luye Pharma (USA) Ltd.1$25
Axsome Therapeutics, Inc.1$17

Products named: INGREZZA, COBENFY, VRAYLAR, UZEDY, CAPLYTA, ARISTADA, INVEGA SUSTENNA, AUSTEDO XR.

Industry payments across MD — which companies pay providers there.